NCT00852761 - A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

August 31, 2009

Conditions

Plaque-Type Psoriasis

Interventions

DRUG

Olux-E Foam

Olux-E (clobetasol propionate 0.05%) foam. Starting at baseline, subjects were to apply twice daily Olux-E foam to the affected elbows and/or knees up to day 15.

DRUG

Clobex lotion

Clobetasol propionate 0.05% lotion. Starting at baseline, subjects were to apply twice daily Clobex lotion to the affected elbows and/or knees up to day 15

Trial Locations (1)

27157

Wake Forest University Health Sciences Department of Dermatology, Winston-Salem